3 results match your criteria: "University of Valencia and Service of Obstetrics and Gynecology[Affiliation]"
Adv Clin Exp Med
September 2021
University of Valencia and Service of Obstetrics and Gynecology, Hospital Clínico Universitario-INCLIVA, Spain.
The receptor activator of nuclear factor-κB (RANK) and its ligand RANKL are members of the tumor necrosis factor (TNF) super-family of cytokines with a role in progestogen-associated malignancies in breast. Basic and clinical data support the participation of the cytokine pathway in metastatic disease and as poor prognosis markers. The value of RANK/RANKL as prognostic indicators in endometrial and ovarian tumors, as well as the data suggesting a potential role of RANK/RANKL in hormone dependent tumorigenesis in the endometrium, have been described.
View Article and Find Full Text PDFMedicine (Baltimore)
June 2021
Department of Pediatrics, Obstetrics and Gynecology, University of Valencia and Service of Obstetrics and Gynecology, INCLIVA, Av Menéndez y Pelayo, Valencia, Spain.
There is debate on the role of estrogens in modulating the risk for atherosclerosis in women. Our purpose was to investigate whether the size of the estrogenic impact was independently associated with variation of carotid intima-media thickness (IMT) in healthy late postmenopausal women. The levels of circulating estrogens have been used in previous studies but the influence of SNPs of the estrogen receptors (ER) α and β have not been investigated.
View Article and Find Full Text PDFJ Obstet Gynaecol Res
March 2018
Department of Pediatrics, Obstetrics and Gynecology, University of Valencia and Service of Obstetrics and Gynecology, INCLIVA, Valencia, Spain.
Aim: We aimed to measure the effectiveness and quality of life (QoL) 10 years after transobturator suburethral tape surgery.
Methods: We carried out a prospective observational study of 42 women assessed 10 years after surgical intervention with the transobturator technique. The main outcome measures were subjective and objective cure or improvement, complications, and changes in QoL.